Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • THERAVANCE INC Analyst Recommendations

  • Analyst Consensus: THRX

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.778 Hold 9
    30 Days Ago 2.750 Hold 8
    60 Days Ago 2.750 Hold 8
    90 Days Ago 2.500 Hold 8
    120 Days Ago 2.500 Hold 8

  • Analyst Ratings: THRX

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    ThinkEquity — Buy 02/20/2009 23.00
    Credit Suisse — Neutral 02/13/2009 18.00
    Robert W. Baird Neutral Outperform 02/05/2009 23.00
    Stanford Research — Buy 11/20/2008 —
    Credit Suisse Outperform Neutral 10/29/2008 10.00
    Susquehanna Financial — Positive 09/05/2008 —
    Stanford Research — Buy 03/04/2008 26.00
    Lehman Brothers — Equal-weight 03/04/2008 15.00
    Robert W. Baird — Neutral 01/15/2008 22.00
    Stanford Research Hold Buy 10/26/2007 34.00
    Cowen & Co — Outperform 08/21/2007 —
    Credit Suisse — Outperform 04/27/2007 39.00
    Rodman & Renshaw — Mkt Outperform 02/09/2007 46.00
    HSBC Securities — Overweight 02/09/2007 44.00
    Piper Jaffray Market Perform Outperform 12/19/2006 38.00
    Goldman Sachs — Neutral 12/04/2006 —
    Rodman & Renshaw — Mkt Outperform 06/28/2006 34.00
    Morgan Stanley Overweight Equal-weight 02/10/2006 —
    Morgan Stanley — Overweight 10/28/2005 25.00
    Morgan Stanley — Overweight 07/25/2005 28.00
    Lehman Brothers — Equal-weight 03/03/2005 21.00
    CSFB — Neutral 01/05/2005 19.00
    Merrill Lynch — Neutral 11/16/2004 —
    Thomas Weisel — Outperform 11/15/2004 —
    Dain Rauscher Strong Buy Buy 03/16/1998 —
    Smith Barney Outperform Buy 06/19/1997 —
    Smith Barney Buy Outperform 06/04/1997 —
    Dain Bosworth — Buy 04/01/1997 —